Insights

  • Date

  • Content Type

  • Reset

Blog

Insights into issues and developments from Advanced Therapies Week

22.03.23

By Dr. Jörg Schneider

Dr. Jörg Schneider, Director – Principal Consultant at BioPharma Excellence, shares key takeaways from Advanced
Read More

Article

Redefining Statistical Significance For Rare Disease Research

15.03.23

By Christian Schneider

Biopharma Excellence recently convened three experts in the world of rare disease in a roundtable
Read More

Article

Back to the drawing board: Redefining statistical significance

28.02.23

By Christian K Schneider

A recent panel debate moderated by Christian K. Schneider, head of Biopharma Excellence, explored emerging
Read More

Article

Achieving Statistical Significance when Global Patient Populations are Limited

28.02.23

By Christian K Schneider

Highlights of a recent panel debate moderated by Christian K Schneider, head of Biopharma Excellence,
Read More

Article

The Right Materials for Success in Bioprinting

28.02.23

By Elena Meurer and Mariya Gromova

Bioprinting has enormous life-changing potential, but it is a complicated field with many regulatory hurdles.
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more